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Abstract
 
Classical studies have demonstrated that in vitro priming of naive CD4 T cells to become T
helper (Th)2 cells is strikingly dependent on interleukin (IL)-4, whereas priming for interferon
(IFN)
 
 
 
 production is IL-12/IFN
 
 
 
-dependent. Therefore, it was quite surprising when we
noted that priming of naive C57BL/6 CD4
 
 
 
 cells to become IL-4 producers was substantially
inhibited by the addition of anti-IFN
 
 
 
 antibodies. This was true using immobilized anti-CD3
and anti-CD28 antibodies or soluble anti-CD3/anti-CD28 and antigen-presenting cells in the
presence or absence of added IL-4. Priming of CD4 T cells from IFN
 
 
 
   
 
 C57BL/6 mice with
immobilized anti-CD3 and anti-CD28 resulted in limited production of IL-4, even with the
addition of 1,000 U/ml of IL-4. Titrating IFN
 
 
 
 into such cultures showed a striking increase
in the proportion of T cells that secreted IL-4 upon challenge; this effect was completely IL-4–
dependent in that it was blocked with anti–IL-4 antibody. Thus, IFN
 
 
 
 plays an unanticipated
but substantial role in Th2 priming, although it is an important Th1 cytokine, and under certain
circumstances a Th1 inducer.
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Introduction
 
T lymphocytes undergo complicated patterns of differenti-
ation from uncommitted precursors to highly competent
effector cells of at least two distinct subsets, Th1 and Th2,
defined both by their functions and their cytokine profiles.
Th1 cells secrete IFN
 
 
 
 and TNF
 
 
 
 and govern cellular im-
munity against intracellular pathogens, whereas Th2 cells
produce IL-4, IL-5, IL-6, and IL-13 and promote antihel-
minthic immunity and allergic inflammation (1, 2). IFN
 
 
 
and IL-4 are prototypic Th1 and Th2 cytokines, respec-
tively, influencing Th1/Th2 cell differentiation, IgG sub-
class switching, IgE production, macrophage stimulation,
and modulation of MHC molecule expression (3). The
mechanisms that induce or influence the process of differ-
entiation of naive Th cells into the two respective subtypes
have been intensely studied. The cytokine milieu during
and after the process of the antigen recognition has been
shown to be a critical determinant (3). It is well docu-
mented that IL-12 and IL-4, acting via signal transducer
and activator of transcription 4 (STAT4) and STAT6, re-
spectively, are major determinants of the Th commit-
ment process (4, 5). Two transcriptional factors, T-bet and
GATA3, play crucial roles in this process (6, 7). Significant
efforts have been concentrated on studies to understand the
hierarchy of regulatory elements involved in Th1 and Th2
intracellular regulatory pathways. The roles that IFN
 
 
 
 plays
remain somewhat controversial. The addition of IFN
 
 
 
 to
cultures of early developing Th2 cells maintains their IL-12R
 
 
 
 2 expression and the ability of these cells to functionally
respond to IL-12, which would be otherwise lost due to
IL-4. However, it does not inhibit the cells’ ability to pro-
duce IL-4 (8). In several rounds of in vitro priming of CD4
T cells, IFN
 
 
 
 was found to be required to stabilize the phe-
notype of Th1 cells (9). In other experiments, IFN
 
 
 
 was
sufficient to induce Th1 polarization of C57BL/6 CD4
cells independently of IL-12 (10), but failed to optimally do
so in BALB/c mice (11). IFN
 
 
 
 was shown to induce T-bet
(12), and retroviral expression of T-bet in Th2 cells sup-
pressed IL-4 production and induced secretion of IFN
 
  
 
(6).
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In contrast, retroviral expression of GATA3 has been
shown to halt Th1 development by down-regulation of
STAT4 (13).
In vivo studies using control of 
 
Leishmania major
 
 infec-
tion as a model of a Th1 response revealed that absence of
IFN
 
 
 
 results in a failure to successfully control the infection
(14, 15) and that CD4 cells may default to the Th2 path-
way (16). However, when animals with a disrupted recep-
tor for IFN
 
 
 
 were similarly infected, Th1 responses still de-
veloped with no evidence for the expansion of Th2 cells
(17). Other studies using experimental autoimmune dis-
eases such as myocarditis showed that the Th1 cytokine IL-
12 was essential for development of the disease, whereas
IFN
 
 
 
 was surprisingly protective (18). Lafaille et al. has
demonstrated that the presence of IFN
 
 
 
 during in vitro
Th2 priming of TCR transgenic T cells produces Th2 sub-
populations with enhanced IL-5 expression (19).
In this paper, we present data that strongly indicate that
the role of T-bet and IFN
 
 
 
 in the polarization of naive Th
cells is even more complex than previously regarded. Com-
plete neutralization of IFN
 
 
 
 in priming cultures of C57BL/6
CD4
 
 
 
 T cells resulted in suboptimal Th2 differentiation,
even in the presence of exogenous IL-4. This was not lim-
ited to a single mouse strain; we were able to reproduce it in
several others. In an effort to better understand this unex-
pected activity of IFN
 
 
 
 in Th2 differentiation, we used
IFN
 
 
 
-deficient C57BL/6 CD4 T cells and tested the effect
of adding IFN
 
 
 
 to their priming cultures. We show that
IFN
 
 
 
 synergized with endogenous IL-4 to enhance the pro-
portion of cells that could be stimulated to produce IL-4 at
the end of the priming cultures. This was even more striking
when exogenous IL-4 was added. Using quantitative PCR
and intracellular staining, we showed that in spite of induc-
ing T-bet, IFN
 
 
 
 synergized with IL-4 in promoting IL-4
production by CD4 cells and their Th2 differentiation. This
was not due to enhancement of levels of GATA3. IFN
 
 
 
 en-
hanced IL-4 mRNA and protein levels, whereas, in the very
same cells, T-bet was strongly up-regulated and GATA-3
levels were unchanged. A portion of the IFN
 
 
 
 effect appears
to be due to preferential survival of IL-4 producers. Finally,
in vivo priming for IL-4 production in IFN
 
 
 
-deficient hosts
reveals that complete absence of IFN
 
 
 
 during the priming
leads to less than optimal Th2 differentiation. Addition of
IFN
 
 
 
 during the priming enhanced Th2 polarization to lev-
els significantly higher than in the wild-type animals.
 
Materials and Methods
 
Mice. 
 
C57BL/6 mice were obtained from the Division of
Cancer Treatment (National Institutes of Health), and IFN
 
 
 
knockout on a C57BL/6 background (C57BL/6 IFN
 
 
 
   
 
) and
DO11.10 transgenic RAG2-deficient BALB/c mice were ob-
tained from Taconic Farms. BALB/c, BALB/c IFN
 
 
 
-deficient
(BALB/c IFN
 
 
 
   
 
), B10.A, and 129S6/SvEv were purchased
from The Jackson Laboratory. Unless specified, the mice were
used at 6–8 wk of age.
 
Monoclonal Antibodies. 
 
Anti–IL-4 (11B11), anti-IFN
 
 
 
 (XMG1.2),
and anti–IL-12 (C17.8) were purchased from Harlan Biosciences
and used at 10 
 
 
 
g/ml. Mouse anti-GATA3 (HG3-31) was pur-
chased from Santa Cruz Biotechnology, Inc. Mouse isotype con-
trol IgG1
 
 
 
 was obtained from BD Biosciences. Cy-5 donkey
F(ab
 
 
 
)2 anti–mouse IgG (Multiple Labeling) was purchased
from Jackson ImmunoResearch Laboratories. Anti–T-bet 4B10
mAb was a gift from L. Glimcher (Harvard Medical School,
Boston, MA).
 
In Vitro Stimulation of Naive T Cells. 
 
LN-derived cells were
depleted of CD8
 
 
 
, B220
 
 
 
, CD16, I-A
 
b
 
 
 
, and NK1.1
 
 
 
 cells by
negative selection using FITC-labeled specific mAbs, anti-FITC
magnetic beads, and an AutoMACS magnetic bead column
(Miltenyi Biotec). Upon purification, the cell populations con-
tained 98–99% of CD4
 
 
 
 cells and 1–2% of non-CD4, non-CD8,
CD3
 
 
 
, TCR
 
 
 
, and Thy1.2
 
 
 
 T cells. More than 95% were
CD44
 
low
 
 CD4
 
 
 
 cells as detected by FACS
 
®
 
 analysis. No FITC
 
 
 
cells were detected. For experiments in Fig. 2 A, cells were fur-
ther sorted for naive phenotype (CD44
 
low
 
, CD62L
 
bright
 
, and
CD4
 
 
 
) to virtually 100% purity. Primary stimulation was per-
formed either by culturing CD4
 
 
 
 cells (3 
 
 
 
 10
 
5
 
 cells in 2 ml of
media per well of 24-well plates) in plates precoated with 5 
 
 
 
g/
ml anti-CD3 and anti-CD28 mAbs or by coculture with irradi-
ated, T cell–depleted APCs (in a CD4/APC ratio of 1:5) and sol-
uble anti-CD3 and anti-CD28 mAbs (5 
 
 
 
g/ml each) for 4 d. In
both cases, 10 U/ml IL-2 was added to the culture media. In
experiments evaluating the proliferative rates, the CD4 T cells
were labeled with carboxyfluorescein diacetate succinimidyl ester
(CFSE; Molecular Probes) at a final concentration of 1.25 
 
 
 
M
before their priming. Primed cells were washed and restimulated
for 6 h by incubation with plate-bound anti-CD3 and anti-CD28
mAbs (5 
 
 
 
g/ml), and for the last 3 h in the presence of 2 
 
 
 
M
monensin (BD Biosciences).
 
Intracellular Cytokine and Transcription Factor Staining. 
 
Re-
stimulated CD4
 
 
 
 cells were washed, harvested, and fixed with
4% paraformaldehyde for 10 min at room temperature. They
were permeabilized with 0.1% Triton X-100 and 0.5% BSA in
PBS before incubation with 2.4G2 mAb anti–Fc
 
 
 
RII-III (Harlan
Biosciences) to block nonspecific binding. They were stained
with FITC-labeled anti-IFN
 
 
 
, PE-anti–IL-4, and APC–anti-
CD4 (all reagents obtained from BD Biosciences). When cells
were examined for transcription factor contents, CyCR anti-
CD4 was used, and anti-GATA3, anti–T-bet, or mouse isotype
control IgG1
 
 
 
 mAbs were used as primary antibodies and de-
tected with Cy-5 donkey F(ab
 
 
 
)2 anti–mouse IgG. Samples were
analyzed using a FACScalibur™ (Becton Dickinson); 10,000
events were collected.
 
Real-Time PCR. 
 
LN-derived CD4
 
 
 
 T cells from either
C57BL/6 IFN
 
 
 
   
 
 or C57BL/6 were cultured in plates pre-
coated with 5 
 
 
 
g/ml anti-CD3 and anti-CD28 mAbs in the
presence of 10 U/ml IL-2 for 24 or 48 h. The cells were col-
lected, total RNA was prepared using SV Total RNA isolation
system (Promega), and 1 
 
 
 
g was reverse transcribed with random
primer hexamers and SuperScript First-Strand synthesis system
(Invitrogen). The amounts of cDNAs specific for GATA3 T-bet
and IL-4 were determined using the ABI Prism 7700 Sequence
Detection System (Applied Biosystems). The individual samples
were normalized using murine 18S rRNA housekeeping gene
expression (Applied Biosystems).
 
In Vivo Priming of CD4 T Cells for IL-4 Production. 
 
Groups
of IFN
 
 
 
   
 
 BALB/c mice (
 
n
 
 
 
 
 
 4) were implanted with mini-
osmotic pumps (Alzet 2001; 1 
 
 
 
l/h; Durect Corp.) containing
1,000 
 
 
 
g OVA (Sigma-Aldrich) in PBS and indicated amounts of
recombinant IFN
 
 
 
 (0, 0.1, 1.0, and 10 
 
 
 
g; BD Biosciences). In
parallel, wild-type BALB/c mice received pumps containing OVA 
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only. The next day, the mice received intraperitoneally naive LN-
derived CD4
 
 
 
 cells from anti-OVA
 
323-339
 
/I-A
 
d
 
 TCR transgenic
DO11.10 
 
  
 
RAG2
 
   
 
 donors (3 
 
 
 
 10
 
6
 
 cells/animal) purified by
negative selection (depleted of CD8
 
 
 
, B220
 
 
 
, CD16, I-A
 
b
 
 
 
, and
DX5
 
 
 
). After 4.5 d, mice were killed, and draining LNs (axillary,
brachial, and inguinal) were harvested. Pooled LN cells from each
animal were restimulated with 3 
 
 
 
M OVA
 
323-339
 
 peptide (Ameri-
can Peptide Company) and 3 
 
 
 
g/ml of soluble anti-CD28 for 8 h;
monensin was added for the last 4 h. IFN
 
 
 
 and IL-4 cytokine con-
tents were determined in clonotypic KJ1-26
 
 
 
CD4
 
 
 
 cells by flow
cytometry as aforementioned. The statistical differences among the
groups were analyzed using Student’s 
 
t
 
 test.
 
Results
 
Priming of CD4
 
 
 
 T Cells for IL-4 Production Is Partially
IFN  Dependent. We observed that when C57BL/6 LN-
derived CD4  T cells were stimulated with plate-bound
anti-CD3 and anti-CD28, neutralization of IFN  resulted
not only in lower proportions of IFN  producers but also
surprisingly in a lower proportion of IL-4 producers upon
restimulation of the cells. This was observed both in ab-
sence or presence of exogenous IL-4 (Fig. 1 A). The same
observations were made when the cells were stimulated
with soluble anti-CD3 and anti-CD28 and irradiated T
cell–depleted splenocytes (Fig. 1 B). Addition of anti-IFN 
mAb reduced the relative proportion of IL-4 producers by
30–70% in various experiments.
To analyze further the role of IFN  in the early stages of
Th2 polarization, we used IFN -deficient C57BL/6 (20)
mice as a source of CD4 cells. The CD4 cells were purified
as described in Materials and Methods and primed by plate-
bound anti-CD3 and anti-CD28 with or without IL-4. De-
fined amounts of IFN  were added to the priming cultures.
Interestingly, the addition of IFN  dramatically enhanced
the proportion of IL-4–producing T cells (Fig. 2 A). This
enhancement was entirely IL-4 dependent; neutralization of
endogenous IL-4 by addition of anti–IL-4 prevented prim-
ing for IL-4 production (Fig. 2 A, left). Sorting CD4 T cells
for naive phenotype (namely CD4 , CD44dull, CD62Lbright,
and NK1.1 ) resulted in no “background” IL-4 priming,
Figure 1. Priming of CD4  T cells for IL-4 pro-
duction under neutral conditions is at least partially
IFN  dependent. C57BL/6 LN-derived CD4  T
cells (purified by depletion of CD8 , B220 ,
CD16, I-Ab , and NK1.1  cells as described in
Materials and Methods) were stimulated for 4 d
with 5  g/ml plate-bound anti-CD3 and anti-
CD28 (A) or with 5  g/ml soluble ones and T
cell–depleted irradiated splenocytes (B). In both
cases, 10 U/ml IL-2 was added to the media.
Blocking mAbs were added at 10  g/ml, and IL-4
was added at 1,000 U/ml. Cells were restimulated
for 6 h with 5  g/ml plate-bound anti-CD3 and
anti-CD28. Percentages of IL-4 and IFN  producers
in the cultures were evaluated by intracellular staining
of fixed permeabilized cells for content of respective
cytokines by flow cytometry. The conditions dur-
ing priming and the relative proportion of IL-4–
producing cells are indicated.Interferon   Enhances Priming for Interleukin 4 Production 1622
presumably because it removed cells that produced the IL-4
needed for priming (Fig. 2 A, right). Such cells did not
show any induction of IL-4–producing capacity upon the
addition of IFN , unless IL-4 was also added. In either cul-
ture, the combination of exogenous IFN  and IL-4 resulted
in a significantly higher relative proportion of Th2 cells than
that induced by IL-4 alone.
We have further investigated how the addition of IFN 
to C57BL/6 IFN     CD4  T cell priming cultures influ-
ences other cytokines made by Th2 cells, namely IL-5, IL-
13, IL-10, and TNF . Adding IFN  to C57BL/6 IFN    
CD4  T cell priming cultures enhanced not only IL-4 but
also IL-10 and IL-13. The enhancement was completely
IL-4 dependent because it was blocked by the addition of
anti–IL-4 (Fig. 2 B). Levels of TNF  were not significantly
influenced by the addition of IFN , and overall levels of
IL-5 were too low to allow meaningful analysis (unpub-
lished data). This is consistent with our observations that
Th2 cells require typically more than one round of priming
to produce higher levels of IL-5.
Quantitative PCR measurements showed that IFN -
enhanced IL-4 mRNA expression was not observed until
48 h of culture. CD4 cells derived either from C57BL/6 or
C57BL/6 IFN     animals were incubated with plate-
bound anti-CD3 and anti-CD28 for 24 or 48 h, and
amounts of IL-4–specific mRNA were determined by
quantitative PCR. There were only minimal changes ob-
served at 24 h. However, at 48 h, neutralization of IFN  in
C57BL/6 CD4 cultures decreased IL-4 mRNA particularly
in the presence of IL-4. Similarly, IFN  dramatically in-
creased IL-4 mRNA in C57BL/6 IFN     CD4  cells
cultured with IL-4 (Fig. 2 C).
The proportion of IL-4–producing cells was diminished
by neutralization of IFN  in the Th2 priming cultures of not
only C57BL/6 CD4 T cells but also in other mouse strains
Figure 2. Addition of IFN  to priming
cultures of C57BL/6 IFN     CD4  T cells
enhances the proportion of IL-4–producing
T cells in an IL-4–dependent manner.
C57BL/6 IFN     CD4  cells were derived
from LNs by depletion of CD8 , B220 ,
CD16, I-Ab , and NK1.1  cells (left). A sub-
population was further purified using an auto-
matic cell sorter collecting only CD4  cells of
naive phenotype, namely CD4 , CD44dull,
CD62Lbright, and NK1.1-PE (right). Each
group was stimulated under the indicated
conditions (IL-4, 1,000 U/ml and anti–IL-4,
10  g/ml). The cells were restimulated, and
proportions of IL-4 producers were ana-
lyzed by intracellular staining and FACS®.
Table I.  Effect of IFN  Neutralization on IL-4 Production in 
Several Mouse Strains
Strain C57BL/6 129S6/SvEv B10.A
C57BL/6
IFN    
Priming 
IL-4 34.5 26.3 23.7 13.5
IL-4 and anti-IFN  21.1 9.2 15.4 13.9
LN-derived CD4  T cells derived from indicated mouse strains were
stimulated for 4 d with 5  g/ml of plate-bound anti-CD3  anti-CD28
in the presence of 10 U/ml IL-2 and IL-4 at 1,000 U/ml without or
with 10  g/ml IFN -blocking mAbs. Cells were restimulated for 6 h
with 5  g/ml plate-bound anti-CD3 and anti-CD28. Percentages of IL-4
in the cultures were evaluated by intracellular staining and FACS®.
Cultures of CD4 cells derived from the IFN -deficient strain served as
a control.Bocek et al. 1623
(Table I). As a control to show that the effects of anti-IFN 
were specific, we show that it has no effect on IL-4 produc-
tion by CD4 T cells from C57BL/6 IFN     mice.
T-bet But Not GATA3 Expression Is Dependent on IFN .
T-bet and GATA3 are key regulatory elements involved in
polarization of T helper cells into Th1 and Th2 phenotypes,
respectively (6, 7). Therefore, we have examined the effects
of IFN  neutralization in priming cultures of C57BL/6
CD4 cells or of the addition of exogenous IFN  to C57BL/6
IFN     on the levels of the two respective transcription
factors. Purified LN CD4 cells derived from C57BL/6 and
C57BL/6 IFN     strains were stimulated with or without
addition of anti-IFN  or IFN , respectively (as described in
Materials and Methods), for 24 or 48 h. The cells were har-
vested, and the amounts of mRNA specific for GATA3 and
T-bet were determined by quantitative RT-PCR (Fig. 3).
Levels of GATA3 were enhanced by IL-4 and not influ-
enced by neutralization of IFN  in C57BL/6 CD4 T cells.
In C57BL/6 IFN     CD4 cells, GATA3 mRNA was also
up-regulated by IL-4, significantly suppressed by anti–IL-4
and modestly diminished by addition of IFN . Thus, the
up-regulation of IL-4 mRNA and ultimately of the propor-
tion of IL-4–producing cells is not due to the effect of IFN 
on GATA3. T-bet expression was strongly induced by
IFN  both in C57BL/6 and C57BL/6 IFN     CD4  T
cells, and it was diminished by IFN  neutralization in
C57BL/6 CD4 T cells priming cultures.
IFN  Up-Regulates T-bet in Both IL-4 Negative and IL-4
Positive Cells. Overexpression of T-bet via infection of
Th2 cells with a retroviral vector has been reported to sup-
press their IL-4 production and to induce a Th1 phenotype
(6). Therefore, we have concentrated on the IFN     cells
where background levels of T-bet were negligible and
where T-bet was highly induced by IFN , and asked
whether the endogenous T-bet is up-regulated in both IL-4
positive and negative cells. IFN     CD4  cells were
primed as aforementioned for 96 h in the presence of IFN ,
IL-4, or IFN  and IL-4, and restimulated for 6 h. Intracel-
lular T-bet and GATA3 were measured by flow cytometry,
gating separately on IL-4 positive or negative cells (Fig. 4).
(B) The exogenous IFN  in
C57BL/6 IFN     CD4  T cell
priming cultures enhances num-
bers of not only IL-4, but also
IL-10 and IL-13–producing cells.
C57BL/6 IFN     CD4  cells
were stimulated as aforemen-
tioned. Fixed and permeabilized
cells were analyzed for intracellular
contents of IL-4, IL-10, and IL-13
by flow cytometry gating on
CD4  cells. The means and stan-
dard deviations of triplicate experi-
ments are presented. (C) IFN 
and IL-4 dramatically increased
IL-4 mRNA above the level in-
duced by IL-4 alone between 24
and 48 h. Neutralization of IFN 
in CD4 priming cultures (wild-
type C57BL/6 strain) decreases
levels of IL-4 mRNA. Relative
ratios of mRNA specific for IL-4
and housekeeping 18S rRNA
were determined by real-time
PCR at 24 and 48 h in either
C57BL/6 or C57BL/6 IFN    
CD4  T cells primed by plate-
bound anti-CD3 and anti-CD28.Interferon   Enhances Priming for Interleukin 4 Production 1624
Consistent with our previous experiments, IFN  increased
the proportions of IL-4 producers. T-bet was not detected
in cells cultured in the absence of IFN  but was induced to
an equivalent degree by IFN  in IL-4  and IL-4  cells. IL-4
did not suppress levels of T-bet. The levels of GATA3 were
slightly higher in IL-4–producing cells; GATA3 was not at
all suppressed by IFN  at the dose we used.
IFN  Diminishes Numbers of IL-4 Negative CD4  Cells
and, Thus, Increases Proportion of IL-4 Producers. Consis-
tent with the antiproliferative/proapoptotic properties of
IFN , we observed decreased cell yields in C57BL/6
IFN     CD4  priming cultures whenever IFN  was
added. This led us to determine the numbers of IL-4  and
IL-4  cells emerging from these cultures. LN-derived
C57BL/6 IFN     CD4  cells were primed with plate-
bound anti-CD3 and anti-CD28 in the presence or ab-
sence of IFN  and/or IL-4 for 4 d. Upon restimulation,
the cells were enumerated, and IL-4 content was deter-
mined as described in Fig. 4. Under the influence of IFN ,
CD4 cell numbers were diminished (Fig. 5 A), but the pro-
portion of IL-4  was significantly enhanced (Fig. 5 B). Ab-
solute numbers of CD4  IL-4  cells were also increased
(Fig. 5 C), but less so than their proportion. The numbers
of CD4  IL-4  were dramatically diminished (Fig. 5 D).
Thus, it appears that the IFN -induced increase in the pro-
portion of IL-4  CD4  cells is at least partially due to their
preferential survival or to the preferential death of the IL-4 
CD4  T cells in the presence of IFN . CFSE-labeling
studies revealed no difference in the proliferation history of
IL-4 producers and nonproducers in the presence or ab-
sence of IFN , suggesting that the observed differences in
cell yield cannot be accounted for by differences in prolif-
erative rate (Fig. 6).
Exogenous IFN  Enhances In Vivo Th2 Priming in an
IFN -deficient Host. Continuous administration of soluble
proteins by a mini-osmotic pump was shown previously to
result in the selective development of Th2 helper cells in
BALB/c mice (21). To test the role played by IFN  during
Th2 priming in vivo, OVA323-339/I-Ad-specific DO11.10
TCR transgenic Rag2    cells were transferred (22) into
groups of IFN     BALB/c mice implanted previously
with a mini-osmotic pump containing OVA and titrated
amounts of recombinant IFN . After 4.5 d of priming, cells
from draining LNs were stimulated with OVA peptide and
anti-CD28 mAb for 8 h. Cellular cytokine content of trans-
ferred OVA-specific T cells was measured by flow cytome-
try after intracellular staining. Results are presented in Fig.
7. The proportions and absolute numbers of IL-4–produc-
ing KJ1-26 CD4  cells were lower in IFN     BALB/c
mice (primed with OVA only) than in wild-type mice. Th2
priming in IFN     BALB/c animals was enhanced dra-
matically by the addition of recombinant IFN  during the
priming process. The IFN     animals that received 1 and
10  g of IFN  during priming had significantly higher pro-
portions of IL-4 producers even compared with the wild-
type mice. These results strongly suggest that efficient in
vivo Th2 priming requires small amounts of IFN , whose
origin remains to be defined. It should be pointed out that
Figure 3. The effect of IFN 
on the mRNA levels of GATA3
and T-bet were studied in
C57BL/6 and C57BL/6 IFN    
strains by real-time PCR. Rela-
tive ratios of mRNA specific for
GATA3 (A), T-bet (B), and
housekeeping 18S rRNA were
determined by real-time PCR at
24 and 48 h in respective strain
CD4  T cells primed by plate-
bound anti-CD3 and anti-CD28
(5   g/ml each). Addition or
neutralization of IFN  in prim-
ing cultures of C57B/6 IFN    
or C57B/6 CD4  T cells, re-
spectively, do not seem to signif-
icantly influence specific mRNA
levels (A), whereas the T-bet ex-
pression is dependent on IFN 
and is strongly induced by it
both in C57B/6 and C57B/6
IFN     CD4  T cells (B).Bocek et al. 1625
the administration of IFN  to the IFN     mice resulted in
an increased yield of KJ1-26 CD4  cells, particularly in
the 10- g IFN  group; the reason for this increase is un-
clear. In addition, the numbers of IL-4–nonproducing KJ1-
26 CD4  cells was not diminished by administration of
IFN  so that the in vivo mechanism of increase in the pro-
portion of IL-4 producers is not likely due to preferential
cell death of the IL-4 nonproducers (Table II).
Discussion
The “classical’ view of Th1/Th2 polarization holds that
the presence of IL12 and/or IFN  during activation of na-
ive CD4 T cells induces the Th1 phenotype, whereas IL-4
plays a central role in Th2 induction. It is now clear that
this concept is far more complex and intricate. BALB/c
mice with disrupted IL-4 loci remain surprisingly suscepti-
ble to L. major infection and fail to mount a Th1 response
Figure 4. Addition of IFN  to priming
cultures of C57BL/IFN     CD4  T cells
increases the proportion of IL-4 producers
and up-regulates T-bet in both IL-4 nega-
tive and IL-4 positive cells, whereas levels of
GATA3 are not diminished. LN-derived
C57BL/6 IFN     CD4  cells (purified by
depletion of CD8 , B220 , CD16, I-Ab ,
and NK1.1  cells as described in Materials
and Methods) were primed with plate-
bound anti-CD3 and anti-CD28 (5  g/ml
each) and 10 U/ml IL-2 in the presence of
indicated cytokines (IFN , 6 ng/ml and IL-4,
1,000 U/ml) followed by 6 h of restimulation.
Cells were fixed and permeabilized, and the
content of IL-4, T-bet, and GATA3 was
determined by flow cytometry as described
in Materials and Methods. Priming condi-
tions are underlined, and the proportions of
IL-4 producers are indicated on the right.
Relative content of intracellular T-bet and
GATA3 are presented by a difference between
specific mean fluorescence index (solid
lines) and that of isotype matched antibody
(dashed lines) gating separately on popula-
tion of IL-4 negative cells (histograms, left)
and IL-4 positive cells (histograms, right).
The net difference in mean fluorescence in-
tensity is presented for each histogram.Interferon   Enhances Priming for Interleukin 4 Production 1626
(23). More recent experiments showed that IL-4 enhances
the development of the Th1 phenotype and helps in the
initiation of delayed type hypersensitivity, in the develop-
ment of cytotoxic T lymphocyte–mediated tumor immu-
nity (24–27), and in the induction of long-term survival of
cytotoxic antigen-specific CD8 T cells (28). At least some
of these findings may be explained by IL-4 action on
APCs. Hochrein et al. reported that IL-4 was important in
the differentiation of dendritic cells that produced IL12 p70
(29). L. major–infected BALB/c mice were rendered resis-
tant to the parasite by injection of IL-4 during the period
of APC activation, causing them to secrete IL-12. When
IL-4 was present during the T cell priming period, a Th2
response developed and the animals were susceptible to the
parasite (30).
Thus far, IFN  has been considered mainly as a Th1 in-
ducer and as a down-regulator of Th2 priming and re-
sponses. Indeed, IFN  has been reported to stabilize the
Th1 phenotype; C57BL/6 IFN     CD4 cells undergoing
several rounds of in vitro priming in the presence of anti–
IL-4 can still be induced to develop into IL-4 producers (9).
Studying the initial stages of in vitro Th1/Th2 polariza-
tion based on cytokine milieu, we observed that complete
neutralization of IFN  in priming cultures results in subop-
Figure 5. IFN  added to priming
cultures of C57BL/6 IFN     CD4  T
cells diminishes cell numbers by prefer-
entially inducing cell death of IL-4 neg-
ative cells and, thus, increases proportion
of IL-4 producers. LN-derived C57BL/6
IFN     CD4  cells (purified by deple-
tion of CD8 , B220 , CD16, I-Ab ,
and NK1.1  cells as described in Mate-
rials and Methods) were primed with
plate-bound anti-CD3 and anti-CD28
(5  g/ml each) and 10 U/ml IL-2 in the
presence of indicated cytokines or anti-
bodies (IFN , 6 ng/ml; IL-4, 1,000
U/ml; and anti–IL-4, 10  g/ml) fol-
lowed by 6 h of restimulation. Cells
were enumerated, fixed, and permeabi-
lized; and the content of IL-4 was deter-
mined by FACS®. Under the influence
of IFN , cell numbers are diminished
(A), but the proportion of IL-4  is sig-
nificantly enhanced (B). Absolute numbers
of CD4  IL-4  cells may be also increased
(C), whereas those of CD4  IL-4  are
dramatically decreased (D). The means
and standard deviations of triplicate ex-
periments are presented.
Figure 6. The proliferative rates of CD4  IL-4 pro-
ducers and nonproducers in the presence of IFN  are
similar. LN-derived C57BL/6 IFN     CD4  cells
(purified by depletion of CD8 , B220 , CD16, I-Ab ,
and NK1.1  cells as described in Materials and Methods)
were labeled with carboxyfluorescein diacetate succin-
imidyl ester (CFSE) and primed with plate-bound anti-
CD3 and anti-CD28 (5  g/ml each) and 10 U/ml IL-2
in the presence of 6 ng/ml IFN  and 1,000 U/ml IL-4
or IL-4 only followed by 6 h of restimulation. CSFE
dilution profiles were examined by flow cytometry gat-
ing on IL-4 positive (histograms, left) or IL-4 negative
CD4  T cells (histograms, right).Bocek et al. 1627
timal Th2 differentiation, marked by lower proportions of
IL-4– and IL-13–producing CD4 cells. This was observed
when the CD4 cells were primed with either plate-bound
or soluble anti-CD3 and anti-CD28. This observation was
reproduced in several mouse strains. It was not due to a
nonspecific effect of the monoclonal anti-IFN  antibody
because the antibody had no effect on IL-4 production in
an IFN -deficient strain.
We have further used IFN     mice to study the ob-
served phenomenon in greater detail. The addition of
IFN  to C57BL/6 IFN     CD4 T cells significantly en-
hanced the proportion of cells making IL-4, IL-10, and IL-
13, but not TNF . Neutralization of endogenous IL-4 by
anti–IL-4 prevented the Th2 priming, indicating that the
IFN -induced Th2 priming enhancement was IL-4 depen-
dent. Indeed, when CD4 T cells were first sorted for naive
phenotype, no spontaneous IL-4 production was observed.
This is presumably because sorting removed “preactivated”
cells that produced the IL-4 needed for priming. Also, na-
ive CD4 T cells only make IL-4 in response to stimulation
with “low affinity” peptides (31) or with low concentra-
tions of cognate peptide (32), and, as we show here, IFN 
did not induce “early” IL-4 production by naive CD4 T
cells. However, when exogenous IL-4 was also added,
IFN  dramatically enhanced the proportion of Th2 cells.
Interestingly, it has been reported recently that LPS classi-
cally induces Th1 responses by stimulating Toll-like recep-
tors or can enhance Th2 APC priming. This Th2-inducing
effect of LPS was reported to be due to its action on APCs
(33). Our observations indicate that IFN  can act directly
on undifferentiated CD4 cells to enhance Th2 priming.
The most persuasive argument in favor of this is that IFN 
Figure 7. IFN  enhances in vivo Th2 priming.
Wild-type and IFN     BALB/c mice were
implanted with a mini-osmotic pump containing
OVA (1 mg/animal) in PBS and recombinant
IFN  as indicated. The next day, LN-derived
naive CD4  cells (purified by depletion of
CD8 , B220 , CD16, I-Ab , and DX5  cells
as described in Materials and Methods) (3   106
cells/mouse) from RAG2-deficient DO11.10
transgenic donors were transferred by i.p. route.
After 4.5 d, animals were killed, and LN cells
were restimulated with 10  M OVA323-339 pep-
tide and 5  g/ml anti-CD28 for 7 h. Cytokine
contents for IL-4 and IFN  in transferred
KJ1-26 CD4  T cells were measured by flow
cytometry as presented for one representative
animal in A. The means and standard errors of
relative (B) and absolute (C) numbers of IL-4–
producing KJ1-26 CD4  T cells for each
group are presented. The p-values of the Student’s
t test comparison between IFN     BALB/c
that received OVA only and a specific group
are indicated (top); lower p-values are represen-
tative of comparison between wild-type and re-
spective groups.Interferon   Enhances Priming for Interleukin 4 Production 1628
enhances IL-4 production in a system in which highly pu-
rified sorted naive CD4  T cells are primed with plate-
bound anti-CD3 and anti-CD28; no other cell types are
present in the culture.
Using a quantitative PCR procedure, we determined
that IFN  began to up-regulate IL-4 mRNA in C57BL/6
IFN     CD4 T cells between 24 and 48 h of culture. It
also strongly induced mRNA for T-bet but it did not di-
minish GATA3 mRNA. The expression of T-bet mRNA
in C57BL/6 CD4 T cells was significantly diminished by
the removal of IFN . The latter findings are consistent
with a previous report suggesting an IFN /T-bet “auto-
crine” loop in Th1 differentiation (12).
The overexpression of retroviral T-bet in Th2 cells
has been reported to suppress IL-4 production and in-
duce IFN  through an IFN -independent mechanism (6).
However, we observed that in IFN     CD4  T cells
primed for 4 d in the presence of IFN  or IFN  and IL-4,
T-bet expression was equally enhanced in IL-4 producers
and IL-4 nonproducers, as determined by flow cytometric
analysis of cells stained for intracellular IL-4 and T-bet con-
tent. T-bet was not detected in cells cultured in the ab-
sence of IFN  and addition of IL-4 did not suppress levels
of T-bet in cells cultured with added IFN . The difference
between our results and those aforementioned that used
retroviral T-bet may have several explanations. In our ex-
perimental system, IFN  is present from the outset of CD4
priming cultures, causing several intracellular events be-
yond induction of T-bet, whereas retroviral infection
requires that cells first be activated, and only T-bet is
induced. In addition, one can expect that retroviral over-
expression will produce sustained levels of intracellular
T-bet that are in excess of those induced in response to
IFN  action on resting or recently activated CD4 T cells.
In our effort to understand the mechanism by which
IFN  enhances IL-4 production, we examined its effects on
intracellular levels of phosphorylated STAT6 during Th2
differentiation. Consistent with previous reports (34), we
did not observe any significant changes (unpublished data).
Furthermore, IFN  did not enhance surface expression of
IL-4R  nor did increasing the concentration of IL-4 used
for priming diminish the capacity of IFN  to enhance IL-4
priming (unpublished data). Thus, it is unlikely that IFN 
acts by increasing the efficiency of IL-4 signaling.
The antiproliferative/proapoptotic properties of IFN 
have been well established (20). Early studies examining
proliferation of T cell clones producing IL-4 versus IFN 
indicated the ability of recombinant IFN  to inhibit prolif-
eration of the IL-4–producing clones (35). A recent paper
indicated that IFN  is required for activation-induced cell
death of T cells and suggested that Th2 cells may be less
sensitive to this effect (36). We observed decreased cell
yields in IFN     CD4  priming cultures in the presence
of IFN . The higher proportion of IL-4 producers induced
by IFN  could be due to their preferential survival or the
preferential death of IL-4 nonproducers. Indeed, in the
presence of IFN , the numbers of CD4  IL-4  cells di-
minished dramatically; however, the absolute number of
IL-4 producers still increased. Thus, although a survival ad-
vantage of IL-4–producing cells may partially explain the
effect of IFN  in increasing priming for IL-4 production, it
cannot fully account for the observed effect.
To determine whether IFN  enhanced IL-4 priming in
vivo, we adapted an experimental system using continu-
ous administration of soluble protein by implanted mini-
osmotic pumps in BALB/c mice. This system has been
shown previously to result in selective induction of anti-
gen-specific Th2 cells (21). IFN     BALB/c mice, which
had received DO11.10 TCR transgenic T cells and
had been implanted with mini-osmotic pumps containing
OVA, developed somewhat fewer cells that produced IL-4
upon subsequent in vitro challenge with peptide than did
similarly primed wild-type BALB/c recipients. Administra-
tion of IFN  in the mini-osmotic pumps that contained
OVA significantly increased priming for IL-4 production in
the IFN     mice; indeed, these animals developed even
higher proportions of IL-4 producers than did the primed
wild-type mice. Administration of IFN  also increased the
yield of TCR transgenic cells. Furthermore, the yield of
IL-4–nonproducing TCR transgenic cells was similar or
greater in the groups that received IFN , supporting the
argument that in vivo the principal mechanism through
Table II. Total Yields of KJ1-26  IL-4 Negative Cells after In Vivo Priming in the Presence or Absence of IFN a
IFN  KO recipients
Total KJ IL-4neg KJ Total KJ IL-4neg KJ Total KJ IL-4neg KJ Total KJ IL-4neg KJ
IFN  dose 0 0.1 1 10
0.130 0.113 0.078 0.066 0.229 0.113 0.452 0.296
0.062 0.058 0.386 0.230 0.094 0.056 0.221 0.156
0.055 0.044 0.187 0.116 0.130 0.060 0.608 0.316
0.150 0.138 0.090 0.071 0.086 0.056 0.764 0.420
Mean (cells   106) 0.099 0.088 0.185 0.120 0.135 0.071 0.512 0.297
aIn millions.Bocek et al. 1629
which IFN  influenced IL-4 production was not by pref-
erentially killing IL-4 nonproducers.
These results suggest that optimal in vivo Th2 priming
requires small amounts of IFN . However, higher concen-
trations of IFN  may well inhibit the Th2 polarization and
induce Th1 cell development, as we observed that the
frequency of IFN -producing cells correlated with the
amount of IFN  present during priming (unpublished
data). These results emphasize the complexity of the Th1/
Th2 polarization process and argue that the significance of
IFN  to a cell undergoing priming will be quite different
depending on whether IL-4 is or is not present. One may
hypothesize that the enhancing effect of IFN  on Th2 po-
larization we have observed may represent a certain regula-
tory measure to prevent extreme polarization of the Th ef-
fectors toward Th1 phenotype. Whether the induction of
T-bet in IFN -treated cells is key to the enhancement of
IL-4 production or one of the myriad other factors induced
by this cytokine is unknown. In preliminary experiments,
we observed that infection of IFN     cells with a T-bet
retrovirus enhances the proportion of cells that produced
IL-4, suggesting that T-bet may be critically involved in
the increased expression of IL-4.
These observations indicate that cytokine regulation of
polarization of CD4 T cells to the Th1 or Th2 phenotype
is substantially more complex than originally envisioned in
studies that examined the dominant roles of IL-12/IFN 
on the one hand and IL-4 on the other. It now seems clear
that precise timing and precise control of amounts of cyto-
kine may be key to whether the dominant effect of IFN  is
to enhance or suppress Th2 priming and, similarly, with re-
gard to IL-4, whether its dominant effect is to increase the
potency of dendritic cells biasing priming to the Th1 phe-
notype or, through its direct action on T cells, to bias
priming to the Th2 phenotype. These experiments empha-
size the need for detailed analysis of in vivo priming condi-
tions if one is to be able to predict the outcome of a given
immunization protocol.
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